Tango Therapeutics OverviewTango Therapeutics Net Income
Profitability analysis for TNGX.
Quarterly Net Income
-$45.51M
↓ 14.14% YoY
As of Mar 2026
Annual Net Income (TTM)
-$107.23M
↑ 18.93% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...